Keyphrases
Aortic Stenosis
100%
Simvastatin
83%
Ezetimibe
83%
Severe Aortic Stenosis
54%
Atrial Fibrillation
46%
All-cause Mortality
32%
Cardiovascular Mortality
28%
Confidence Interval
28%
Hazard Ratio
27%
New-onset Atrial Fibrillation
24%
Left Atrial Appendage
22%
Heart Failure
21%
Open Heart Surgery
21%
Myocardial Infarction
19%
Aortic Valve Replacement
18%
Statins
16%
Postoperative Atrial Fibrillation
16%
Non-severe
16%
Cardiovascular Magnetic Resonance
16%
Ventilation-perfusion Ratio
16%
Moderate to Severe
15%
Low-density Lipoprotein
14%
Sudden Cardiac Death
14%
Cardiovascular Events
13%
Statin Therapy
13%
Lipid-lowering Therapy
12%
Left Ventricular Hypertrophy
12%
Antihypertensive Treatment
12%
Lipid-lowering
12%
Magnetic Resonance Perfusion
11%
Stroke Risk
11%
Myocardial Blood Flow
11%
Perfusion Defect
11%
Randomized multicenter Trial
11%
Life Studies
11%
Pixel-wise
11%
New Onset
11%
Fibrosis
11%
Hypertrophic Cardiomyopathy
11%
Mechanically Ventilated Patients
11%
Perfusion SPECT
11%
High Risk
10%
Late Gadolinium Enhancement
10%
Aortic Valve Stenosis
9%
Prognostic Impact
8%
Acute Myocardial Infarction
8%
Percutaneous Left Atrial Appendage Closure
7%
Systolic Blood Pressure
7%
Myocardium
7%
Peak Aortic Jet Velocity
7%
Medicine and Dentistry
Aortic Stenosis
88%
Ezetimibe
51%
Simvastatin
51%
Atrial Fibrillation
46%
Cardiovascular System
24%
All Cause Mortality
23%
Open Heart Surgery
22%
Hazard Ratio
21%
Apoplexy
20%
Cardiac Magnetic Resonance Imaging
20%
Heart Muscle Blood Flow
16%
Lung Ventilation
16%
Heart Failure
16%
Blood Pressure
14%
Sudden Cardiac Death
12%
Cardiovascular Mortality
12%
Fibrosis
12%
Antihypertensive Therapy
11%
Lung Diffusion Capacity
11%
Aortic Valve Stenosis
11%
Hypertrophic Cardiomyopathy
11%
Single-Photon Emission Computed Tomography
11%
Lung Transplantation
11%
Gadolinium
10%
Aortic Valve Replacement
10%
Myocardial Infarction
10%
Electrocardiogram
9%
Proportional Hazards Model
9%
Ezetimibe/Simvastatin
9%
Anticoagulation
8%
Statin
8%
Biological Marker
8%
Systolic Blood Pressure
7%
CHA2DS2-VASc Score
7%
Transient Ischemic Attack
6%
Brain Ischemia
6%
Echocardiography
6%
Hemodynamic
6%
Coronary Artery Disease
6%
Epileptic Absence
6%
Renin Angiotensin Aldosterone System
6%
QRS Interval
6%
Cardiovascular Risk
6%
Aortic Valve
6%
Heart Muscle Ischemia
6%
Retrospective Cohort Study
6%
Prevalence
5%
Disease
5%
Scintigraphy
5%
Resting Heart Rate
5%
Pharmacology, Toxicology and Pharmaceutical Science
Aortic Stenosis
73%
Simvastatin
47%
Ezetimibe
46%
All Cause Mortality
30%
Atrial Fibrillation
22%
New-Onset Atrial Fibrillation
19%
Heart Failure
17%
Heart Infarction
16%
Statin (Protein)
15%
Low Density Lipoprotein
12%
Cohort Study
12%
Hydroxymethylglutaryl Coenzyme A Reductase Inhibitor
12%
Antihypertensive Agent
11%
Ezetimibe Plus Simvastatin
11%
Transthyretin
11%
Disease
7%
Cardiovascular Mortality
7%
Sudden Cardiac Death
7%
Biological Marker
6%
Renin
6%
Angiotensin
6%
Heart Left Ventricle Hypertrophy
6%
Tetramer
6%
Cardiovascular Risk
6%
Brain Natriuretic Peptide
5%
Infarction
5%
Placebo
5%
Tissue Inhibitor of Metalloproteinase
5%
Urokinase Receptor
5%
Metalloproteinase Inhibitor
5%
Coronavirinae
5%
Troponin T
5%
Fibrosis
5%
Cataract
5%
Pulmonary Hypertension
5%
Sepsis
5%
Aortic Valve Stenosis
5%
Carbon Monoxide
5%
Hyponatremia
5%
Gadolinium
5%
Aortic Valve Disease
5%
Losartan
5%
Atenolol
5%
Lung Embolism
5%
Low Density Lipoprotein Cholesterol
5%
